Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy
REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007
VOLKER DIEHL, University of Cologne
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
Long-term results presented at the ASCO Annual Meeting have given further support to the use of an escalated BEACOPP regimen in patients with Hodgkin’s disease. Volker Diehl, of the University of Cologne, discussed his latest data with George Canellos, of the Dana-Farber Cancer Institute in Boston, and Peter Goodwin.
[...] After her talk in the lymphoma session, Sandra Horning talked with Sarah Maxwell about her group’s latest results. To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations. …more [...]
[...] After her talk in the lymphoma session, Sandra Horning talked with Sarah Maxwell about her group’s latest results. To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations. …more [...]